Deep vein thrombosis in cancer: the scale of the problem and approaches to management.
about
Erythropoietin or Darbepoetin for patients with cancerThe risk of cancer progression in women with gynecological malignancies and thrombophilic polymorphisms: a pilot case-control study.Cancer-associated thrombosis.Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: distinct role of PAR1 and PAR3 signaling.Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience.Implementing thrombosis guidelines in cancer patients: a review.Risk factors for venous and arterial thrombosisBreast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studies.Preoperative Chemoprophylaxis is Safe in Major Oncology Operations and Effective at Preventing Venous Thromboembolism.Prevention and treatment of venous thromboembolism in patients with cancer.The Role of Inferior Vena Cava Filters in Cancer PatientsRegional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis StudyVenous thromboembolic events and organ-specific occult cancers: a review and meta-analysis.Venous thromboembolism prophylaxisVenous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemiaPrevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines.Retrospective review of hemoglobin and/or hematocrit levels with occurrence of thrombosis in cancer patients treated with erythropoiesis stimulating agents.Management of venous thromboembolism in cancer patients: ESMO clinical recommendations.Cancer and thrombosis: implications of published guidelines for clinical practice.Acute limb ischemia in cancer patients: aggressive treatment is justified.Venous Thromboembolism in Cancer: Frequently Asked Questions When Guidelines are Inconclusive.Venous thromboembolism in cancer patients: risk assessment, prevention and management.Unprovoked venous thromboembolism and subsequent cancer risk: a population-based cohort study.Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.Risk factors for venous thromboembolic events in cancer patients.Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management.Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the 'SENDO experience'.Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?Chills and limb pain following administration of low-molecular-weight heparin for treatment of acute venous thromboembolism.Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study.Local low-dose thrombolysis for safe and effective treatment of venous port-catheter thrombosis.
P2860
Q24245464-2528F043-9689-4232-BC24-A74BFD2C457AQ33347978-A7A80FC3-3D9B-476C-9AEA-25D9F60EC198Q33389006-E7A47837-3EC6-4369-9701-4C2215CB9EFEQ33959220-6054F647-53CF-4A98-8059-ED2889205237Q34130749-6370CDBC-CD24-41D8-AF45-D6586EF9AA2EQ34463482-41DE6359-0075-4712-8D67-65AF53A2FCB1Q34988616-03155FF5-257D-4E8E-BC74-9AAE92EDC831Q35490056-1B0B4705-F042-4014-B57F-BD532434E1DDQ36166850-B7C3DBFD-6015-4CB6-A272-62C5C7D87D4FQ36510392-096B5074-6AA7-4FDA-B2F2-DBD1BCC9365EQ36595944-C0C3DA45-7C4E-423E-AF78-ED32D3679EB8Q36888938-BF8354EA-DB70-4E03-A774-4A8494EFA1F4Q37060686-BCDA7522-4B90-4722-A0D7-C430F028A89AQ37088527-C048BCED-A088-47BC-A38B-C72F10FA5474Q37104836-EC817A28-78BC-4928-B2C0-F239A1C6A052Q37152911-78C5E6D2-6189-4B15-9144-1F08166CFAC6Q37265242-794DA974-102C-42FB-8DA0-8922553F08CDQ37411808-E4E7580A-00B7-4CB3-9ABC-C4B9D313261AQ37489073-0057640A-EBA7-4B6F-A263-E8F8431875A5Q37533816-E932C218-B33F-4487-A02E-17AA3C9B9E7EQ38213486-486888B9-08C0-4AB7-9F64-735EFFCFFE72Q38381351-0779E943-1682-4EB6-A19D-E7C5AB911306Q38751462-4F29B52E-B5FC-45E4-8028-0459C019EAD6Q40126111-4BCD6084-27FE-4BCD-8EB2-C8313F30C101Q40293384-AF7875AB-5A8D-4B9D-8267-2FB0689F4F1AQ40494174-6631B714-1477-4A18-A869-4BBABCA22D72Q43016566-97C69C56-963C-4FF6-9EAF-33AD481D4DFCQ43431686-28AD973D-6132-442D-8C85-D9EBE55BEBC5Q44200568-D9B98A39-DA91-4153-986A-6CCE54047BCBQ47371128-5D5CC804-BC92-4FB5-B18D-F384F3790526Q47772034-1B96863E-39E0-48D0-B1DD-74F7DDFC8BE0Q51108756-DAE7457D-C727-4996-BBEC-EE1E3EC724B1
P2860
Deep vein thrombosis in cancer: the scale of the problem and approaches to management.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Deep vein thrombosis in cancer: the scale of the problem and approaches to management.
@ast
Deep vein thrombosis in cancer: the scale of the problem and approaches to management.
@en
type
label
Deep vein thrombosis in cancer: the scale of the problem and approaches to management.
@ast
Deep vein thrombosis in cancer: the scale of the problem and approaches to management.
@en
prefLabel
Deep vein thrombosis in cancer: the scale of the problem and approaches to management.
@ast
Deep vein thrombosis in cancer: the scale of the problem and approaches to management.
@en
P2860
P356
P1433
P1476
Deep vein thrombosis in cancer: the scale of the problem and approaches to management.
@en
P2093
L Zacharski
P2860
P304
P356
10.1093/ANNONC/MDI165
P577
2005-03-31T00:00:00Z